TY - JOUR T1 - Cataract in the human lens: a systematic review of proteomic studies JF - medRxiv DO - 10.1101/19009035 SP - 19009035 AU - Christina Karakosta AU - Argyrios Tzamalis AU - Michalis Aivaliotis AU - Ioannis Tsinopoulos Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/03/19009035.abstract N2 - Background/Aim The aim of this systematic review is to identify all the available data on human lens proteomics with a critical role to age-related cataract formation in order to elucidate the physiopathology of the aging lens.Methods We searched on Medline and Cochrane databases. The search generated 328 manuscripts. We included nine original proteomic studies that investigated human cataractous lenses.Results Deamidation was the major age-related post-translational modification. There was a significant increase in the amount of αA-crystallin D-isoAsp58 present at all ages, while an increase in the extent of Trp oxidation was apparent in cataract lenses when compared to aged normal lenses. During aging, enzymes with oxidized cysteine at critical sites included GAPDH, glutathione synthase, aldehyde dehydrogenase, sorbitol dehydrogenase, and PARK7.Conclusion D-isoAsp in αA crystallin could be associated with the development of age-related cataract in human, by contributing to the denaturation of a crystallin, and decreasing its ability to act as a chaperone. Oxidation of Trp may be associated with nuclear cataract formation in man, while the role of oxidant stress in age-related cataract formation is dominant.Synopsis The oxidative stress and the post-translational modification of deamidation in lens crystallins seem to play a significant role in the formation of age-related cataract in human.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AFunding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesNot applicable(GSH)Glutathione(SH)Sulfhydryl(PRISMA)Preferred Reporting Items for Systematic Reviews and Meta-Analyses (WI-US) Water-insoluble-urea soluble(WI-UI)Water-insoluble-urea insoluble(ARNC)Age-related nuclear cataract(NEM)N-ethylmaleimide(CM)Carboxymethyl(HMW)High Molecular Weight(Gln)Glutamine(FABP5)Fatty acid-binding protein(CRYAB)Alpha-crystallin B chain(BHMT1)Betaine-homocysteine S-methyltransferase-1(RLSC)Regenerative lenses with secondary cataract(CC)Congenital cataract(ARC)Age-related cataract(VEGF)Vascular endothelial growth factor(hγD)human γD-crystallin ER -